c(RGDyk)-modified nanoparticles encapsulating quantum dots as a stable fluorescence probe for imaging-guided surgical resection of glioma under the auxiliary UTMD

References

• Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell. 2012;149(1):36–47.
   PubMed Web of Science ®Google Scholar
• Shergalis A, Bankhead A 3rd, Luesakul U, et al. Current challenges and opportunities in treating glioblastoma. Pharmacol Rev. 2018;70(3):412–445.
   PubMed Web of Science ®Google Scholar
• Sepulveda JM, Sanchez-Gomez P, Vaz Salgado MA, et al. Dacomitinib: an investigational drug for the treatment of glioblastoma. Expert Opin Investig Drugs. 2018;27(10):823–829.
   PubMed Web of Science ®Google Scholar
• Qiu XX, Chen L, Wang CH, et al. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma. Medicine (Baltimore). 2014;93(8):e57.
   PubMed Web of Science ®Google Scholar
• Parker NR, Khong P, Parkinson JF, et al. Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol. 2015;5:55.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Yu TS, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522–526.
   PubMed Web of Science ®Google Scholar
• Martirosyan NL, Cavalcanti DD, Eschbacher JM, et al. Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor. J Neurosurg. 2011;115(6):1131–1138.
   PubMed Web of Science ®Google Scholar
• Jenkinson MD, Barone DG, Bryant A, et al. Intraoperative imaging technology to maximise extent of resection for glioma. Cochrane Database Syst Rev. 2018;1:CD012788.
   PubMed Web of Science ®Google Scholar
• Doglietto F, Belotti F, Panciani P, et al. High-definition 3-dimensional exoscope for 5-ALA glioma surgery: 3-dimensional operative video. Oper Neurosurg (Hagerstown). 2019.
   Google Scholar
• Martinez-Moreno M, Kiesel B, Woehrer A, et al. Ex-vivo analysis of quantitative 5-ALA fluorescence intensity in diffusely infiltrating gliomas with a handheld spectroscopic probe: correlation with histopathology, proliferation and microvascular density. Photodiagn Photodyn Ther. 2019;27:354–361.
   PubMed Web of Science ®Google Scholar
• Su X, Huang QF, Chen HL, et al. Fluorescence-guided resection of high-grade gliomas: a systematic review and meta-analysis. Photodiagn Photodyn Ther. 2014;11(4):451–458.
   PubMed Web of Science ®Google Scholar
• Michalet X, Pinaud PF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005;307(5709):538–544.
   PubMed Web of Science ®Google Scholar
• Cai W, Shin DW, Chen K, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006;6(4):669–676.
   PubMed Web of Science ®Google Scholar
• Arndt-Jovin DJ, Kantelhardt SR, Caarls W, et al. Tumor-targeted quantum dots can help surgeons find tumor boundaries. IEEE Transon Nanobiosci. 2009;8(1):65–71.
   PubMed Web of Science ®Google Scholar
• Al-Jamal WT, Al-Jamal KT, Tian B, et al. Lipid-quantum dot bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivo. ACS Nano. 2008;2(3):408–418.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang W, Zhao D, et al. Water-soluble fluorescent CdTe/ZnSe core/shell quantum dot: aqueous phase synthesis and cytotoxicity assays. J Nanosci Nanotechnol. 2015;15(6):4648–4652.
   PubMed Web of Science ®Google Scholar
• Lovrić J, Bazzi HS, Yan C, et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med. 2005;83(5):377–385.
   PubMed Web of Science ®Google Scholar
• Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004;4(1):11–18.
   PubMed Web of Science ®Google Scholar
• Zheng H, Mortensen LJ, DeLouise LA. Thiol antioxidant-functionalized CdSe/ZnS quantum dots: synthesis, characterization, cytotoxicity. J Biomed Nanotechnol. 2013;9(3):382–392.
   PubMed Web of Science ®Google Scholar
• Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65(1):71–79.
   PubMed Web of Science ®Google Scholar
• van Schooneveld MM, Vucic E, Koole R, et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett. 2008;8(8):2517–2525.
   PubMed Web of Science ®Google Scholar
• Koffie RM, Farrar CT, Saidi LJ, et al. Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci USA. 2011;108(46):18837–18842.
   PubMed Web of Science ®Google Scholar
• Beduneau A, Saulnier P, Benoit JP. Active targeting of brain tumors using nanocarriers. Biomaterials. 2007;28(33):4947–4967.
   PubMed Web of Science ®Google Scholar
• Nance EA, Woodworth GF, Sailor KA, et al. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med. 2012;4(149):149ra119.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Du X, et al. Increasing of blood–brain tumor barrier permeability through transcellular and paracellular pathways by microbubble-enhanced diagnostic ultrasound in a C6 glioma model. Front Neurosci. 2017;11:86.
   PubMed Web of Science ®Google Scholar
• Weng KC, Hashizume R, Noble CO, et al. Convection-enhanced delivery of targeted quantum dot–immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine. 2013;8(12):1913–1925.
   PubMed Web of Science ®Google Scholar
• Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2(2):91–100.
   PubMed Web of Science ®Google Scholar
• Gao H, Xiong Y, Zhang S, et al. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Mol Pharm. 2014;11(3):1042–1052.
   PubMed Web of Science ®Google Scholar
• Fisher MJ, Gunn B, Harms CS, et al. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa. J Med Chem. 1997;40(13):2085–2101.
   PubMed Web of Science ®Google Scholar
• Saraf P, Li X, Wrischnik L, et al. In vitro and in vivo efficacy of self-assembling RGD peptide amphiphiles for targeted delivery of paclitaxel. Pharm Res. 2015;32(9):3087–3101.
   PubMed Web of Science ®Google Scholar
• Hu G, Liu C, Liao Y, et al. Ultrasound molecular imaging of arterial thrombi with novel microbubbles modified by cyclic RGD in vitro and in vivo. Thromb Haemost. 2012;107(1):172–183.
   PubMed Web of Science ®Google Scholar
• Doolittle ND, Muldoon LL, Culp AY, et al. Delivery of chemotherapeutics across the blood–brain barrier: challenges and advances. Adv Pharmacol. 2014;71:203–243.
   PubMedGoogle Scholar
• Vykhodtseva N, McDannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics. 2008;48(4):279–296.
   PubMed Web of Science ®Google Scholar
• Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des. 2012;18(15):2166–2183.
   PubMed Web of Science ®Google Scholar
• Mayer CR, Geis NA, Katus HA, et al. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv. 2008;5(10):1121–1138.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Frutos B, Otero-Ortega L, Ramos-Cejudo J, et al. Enhanced brain-derived neurotrophic factor delivery by ultrasound and microbubbles promotes white matter repair after stroke. Biomaterials. 2016;100:41–52.
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao YZ, Wong HL, et al. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine. 2014;9:2241–2257.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Lu CT, Li XK, et al. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery. Expert Opin Drug Deliv. 2013;10(7):987–1001.
   PubMed Web of Science ®Google Scholar
• Tung YS, Vlachos F, Feshitan JA, et al. The mechanism of interaction between focused ultrasound and microbubbles in blood–brain barrier opening in mice. J Acoust Soc Am. 2011;130(5):3059–3067.
   PubMed Web of Science ®Google Scholar
• Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 2002;310(3):257–270.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Lin Q, Wong HL, et al. Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery. J Control Release. 2016;224:112–125.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu Y, Jiang X, et al. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release. 2004;96(1):135–148.
   PubMed Web of Science ®Google Scholar
• Chao CC, Kan D, Lo TH, et al. Induction of neural differentiation in rat C6 glioma cells with taxol. Brain Behav. 2015;5(12):e00414.
   PubMed Web of Science ®Google Scholar
• Ristic S, Miric M, Jovic S, et al. Histological characteristics and markers of proliferation and differentiation in rat brain with experimental glioma. Vojnosanit Pregl. 2014;71(9):828–832.
   PubMed Web of Science ®Google Scholar
• Krivosheya D, Prabhu SS, Weinberg JS, et al. Technical principles in glioma surgery and preoperative considerations. J Neurooncol. 2016;130(2):243–252.
   PubMed Web of Science ®Google Scholar
• Etame AB, Diaz RJ, Smith CA, et al. Focused ultrasound disruption of the blood–brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus. 2012;32(1):E3.
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood–brain barrier disruption. Ultrasound Med Biol. 2008;34(6):930–937.
   PubMed Web of Science ®Google Scholar
• Sheikov N, McDannold N, Sharma S, et al. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol. 2008;34(7):1093–1104.
   PubMed Web of Science ®Google Scholar
• Kroll RA, Neuwelt EA. Outwitting the blood–brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery. 1998;42(5):1083–1099.
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Vykhodtseva N, et al. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl. 2003;86:555–558.
   PubMedGoogle Scholar
• Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm. 2006;3(5):472–487.
   PubMed Web of Science ®Google Scholar
• Kenny LM, Coombes RC, Oulie I, et al. Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med. 2008;49(6):879–886.
   PubMed Web of Science ®Google Scholar
• Tian JL, Zhao YZ, Jin Z, et al. Synthesis and characterization of Poloxamer 188-grafted heparin copolymer. Drug Dev Ind Pharm. 2010;36(7):832–838.
   PubMed Web of Science ®Google Scholar
• Homayouni A, Sadeghi F, Nokhodchi A, et al. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 2014;17(5):322–331.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zheng C, Zhao H, et al. Tumor cell pH detection based on fluorescence characteristics of CdSe quantum dots. Technol Health Care. 2019;27(5930):1–9.
   Google Scholar
• Azzazy HM, Mansour MM, Kazmierczak SC. From diagnostics to therapy: prospects of quantum dots. Clin Biochem. 2007;40(13–14):917–927.
   PubMed Web of Science ®Google Scholar
• Smith AM, Duan H, Mohs AM, et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev. 2008;60(11):1226–1240.
   PubMed Web of Science ®Google Scholar
• Swift BJ, Baneyx F. Microbial uptake, toxicity, and fate of biofabricated ZnS:Mn nanocrystals. PLoS One. 2015;10(4):e0124916.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang M. Review of in vitro toxicological research of quantum dot and potentially involved mechanisms. Sci Total Environ. 2018;625:940–962.
   PubMed Web of Science ®Google Scholar
• Ruan H, Chen X, Xie C, et al. Stapled RGD peptide enables glioma-targeted drug delivery by overcoming multiple barriers. ACS Appl Mater Interfaces. 2017;9(21):17745–17756.
   PubMed Web of Science ®Google Scholar
• Belhadj Z, Ying M, Cao X, et al. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. J Control Release. 2017;255:132–141.
   PubMed Web of Science ®Google Scholar
• Belhadj Z, Zhan C, Ying M, et al. Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment. Oncotarget. 2017;8(40):66889–66900.
   PubMedGoogle Scholar
• Liu J, Liu Y, Michalska AE, et al. Distribution and retention of cadmium in metallothionein I and II null mice. Toxicol Appl Pharmacol. 1996;136(2):260–268.
   PubMed Web of Science ®Google Scholar
• Parani S, Pandian K, Oluwafemi OS. Gelatin stabilization of quantum dots for improved stability and biocompatibility. Int J Biol Macromol. 2018;107(Pt A):635–641.
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu Q, Tao J, et al. Near infrared quantum dots in biomedical applications: current status and future perspective. Wires Nanomed Nanobiotechnol. 2018;10(3):e1483.
   Google Scholar